UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2020 2020-11-09 Future report Set alerts
Q2 2020 2020-08-06 -0.28 -0.28
Q1 2020 2020-05-07 -0.25 -0.25
Q4 2019 2020-03-06 -0.27 -0.27
Q3 2019 2019-11-06 -0.37 -0.37
Q2 2019 2019-08-09 -0.41 -0.41
Q1 2019 2019-05-07 -0.42 -0.42
Q4 2018 2019-03-06 -0.45 -0.45
Q3 2018 2018-11-07 -0.39 -0.39
Q2 2018 2018-08-07 -0.42 -0.42

Ratings

2016-06-23 Reiterated Rating Leerink Swann Buy
2016-06-23 Reiterated Rating Wedbush Outperform $24.00
2016-06-22 Reiterated Rating Cantor Fitzgerald Buy
2016-05-10 Reiterated Rating Leerink Swann Buy $17.00
2016-03-31 Initiated Coverage Ladenburg Thalmann Buy $21.00
2016-03-16 Reiterated Rating Leerink Swann Outperform $20.00
2016-03-09 Lower Price Target JPMorgan Chase & Co. Market Outperform $26.00 to $21.00
2016-03-09 Lower Price Target JMP Securities Market Outperform $26.00 to $21.00
2016-03-08 Initiated Coverage Cantor Fitzgerald Buy $19.00
2016-03-07 Lower Price Target Leerink Swann Outperform $30.00 to $20.00
2016-03-04 Reiterated Rating Wedbush Outperform $24.00
2016-03-03 Initiated Coverage Citigroup Inc. Buy $15.00
2016-01-05 Reiterated Rating Wedbush Outperform $24.00
2015-12-18 Initiated Coverage BTIG Research Buy $33.00
2015-09-22 Initiated Coverage BTIG Research Buy $33.00
2015-09-03 Reiterated Rating Wedbush Outperform $24.00
2015-08-19 Reiterated Rating Wedbush Buy
2015-08-18 Boost Price Target Wedbush Outperform $19.00 to $24.00
2015-06-04 Boost Price Target Leerink Swann Outperform $22.00 to $25.00
2015-05-07 Lower Price Target Citigroup Inc. Buy $20.00 to $14.00
2015-05-06 Lower Price Target Leerink Swann Outperform $32.00 to $22.00
2015-05-06 Lower Price Target JMP Securities Market Outperform $32.00 to $24.00
2015-02-03 Lower Price Target Leerink Swann Outperform $36.00 to $32.00
2015-02-02 Reiterated Rating Wedbush Outperform $31.00
2014-07-14 Initiated Coverage Wedbush Outperform $31.00
2014-07-14 Initiated Coverage Leerink Swann Outperform $32.00
2014-07-14 Initiated Coverage JMP Securities Outperform $26.00
2014-07-14 Initiated Coverage Citigroup Inc. Buy $27.00
2016-06-23 Reiterated Rating Leerink Swann Buy
2016-06-23 Reiterated Rating Wedbush Outperform $24.00
2016-06-22 Reiterated Rating Cantor Fitzgerald Buy
2016-05-10 Reiterated Rating Leerink Swann Buy $17.00
2016-03-31 Initiated Coverage Ladenburg Thalmann Buy $21.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
KERINS PATRICK J 47.23%  (8752543) ARDX / CLVS / CRCM / CVT / ECHO / ECOM / EPZM / HIVE / HPTX / LOXO / MM / ROKA / SNSS / SURF / SYBX / TSRO /
BARRETT M JAMES 47.23%  (8752543) ADNC / ARDX / CLVS / CRCM / CVT / DATA / ECHO / EPZM / FOLD / GLYC / HIVE / HPTX / INWK / LOXO / ROKA / SNSS / SUPN / SURF / SYBX / TRGT / TSRO / VTAE / WIFI / XOOM / ZSAN /
New Enterprise Associates 12, Limited Partnership 47.23%  (8752543) ARDX / ECHO / ECOM / HPTX / OPWR / TNTR / TRVN / ZSAN /
DRANT RYAN D 40.41%  (7488893) ADNC / ARDX / CLVS / CRCM / CVT / DATA / ECHO / EPZM / HIVE / HPTX / INWK / LOXO / ROKA / SNSS / TSRO / XOOM /
NEA 15 GP, LLC 14.38%  (2665519) ARDX /
MAKOWER JOSHUA 14.38%  (2665519) ABIO / AKAO / ARDX / AVEO / ONTY /
Sonsini Peter W. 14.38%  (2665519) ABIO / AKAO / ARDX / AVEO / LOXO / ONTY / SURF / SYBX /
Florence Anthony A. Jr. 14.38%  (2665519) ABIO / AKAO / ARDX / AVEO / CVT / LOXO / ONTY / SURF / SYBX /
Viswanathan Ravi 14.38%  (2665519) ABIO / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / EPZM / HIVE / LOXO / ONTY / ROKA / SURF / SYBX / TSRO /
KOLLURI KRISHNA KITTU 14.38%  (2665519) ADNC / AKAO / ARDX / CLVS / CRCM / CVT / DATA / ECHO / EPZM / HIVE / HPTX / INWK / LOXO / ROKA / SNSS / SUPN / TSRO / XOOM /
BARRIS PETER J 14.38%  (2665519) ABIO / ADNC / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / DATA / ECHO / EPZM / GLYC / GRPN / HIVE / HPTX / INWK / LOXO / ONTY / ROKA / SNSS / SUPN / SURF / SYBX / TRGT / TSRO / VTAE / WIFI / XOOM / ZHNE /
Weller Harry R 14.38%  (2665519) ARDX / CLVS / CRCM / CVT / EPZM / HIVE / LOXO / OPWR / ROKA / TSRO /
SANDELL SCOTT D 14.38%  (2665519) ABIO / ADNC / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / DATA / ECHO / EPZM / FIO / GLYC / HIVE / HPTX / INWK / LOXO / ONTY / ROKA / SNSS / SUPN / SURF / SYBX / TRGT / TSRO / VTAE / WDAY / WIFI / XOOM /
Sakoda Jon 14.38%  (2665519) ABIO / AKAO / ARDX / AVEO / ONTY / OPWR /
SCHULTZ PETER G 4.91%  (910339) ARDX /
Seeto Reginald Chief Operating Officer 0.85%  (158133) ARDX /
RAAB MICHAEL President & CEO 0.53%  (99038) ARDX / FOLD /
Jacobs Jeffrey W VP, Chemistry 0.37%  (68450) ARDX /
Rosenbaum David P. SVP, Drug Development 0.36%  (66641) ARDX /
CMEA Ventures VII LP 0.34%  (63490) ARDX / ASPX / NEOS /
Korner Paul EVP, Chief Medical Officer 0.29%  (54623) ARDX /
Kaufmann Mark Chief Financial Officer 0.26%  (48588) ARDX /
GRAMMER ELIZABETH A VP, General Counsel 0.21%  (38894) ARDX /
MOTT DAVID M 0.18%  (33877) ABIO / AKAO / ARDX / AVEO / CLVS / CRCM / CVT / EPZM / HIVE / LOXO / ONTY / ROKA / SURF / SYBX / TSRO /
Rodgers Richard J 0.15%  (26993) ARDX / RNN / TSRO /
JUE GEORGE VP, Operations & Facilities 0.13%  (24134) ARDX /
Bertrand William C JR 0.12%  (21481) ARDX / INFI / SLXP /
Caldwell Jeremy S EVP, Chief Scientific Officer 0.10%  (17985) ARDX /
RINGOLD GORDON 0.08%  (15000) ALXA / ARDX /
Arasaratnam Narani VP, Corporate Controller 0.01%  (1232) ARDX /

Comments